Use of traditional and complementary medicine for COVID 19 prophylaxis among healthcare professionals and students in Jordan: A cross-sectional study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
17
07
2022
accepted:
14
09
2022
entrez:
20
10
2022
pubmed:
21
10
2022
medline:
25
10
2022
Statut:
epublish
Résumé
There is inadequate evidence to recommend the use of any traditional and complementary medicine (T&CM) methods such as vitamin, mineral, herbal or other dietary supplements to prevent or treat COVID 19. Members of the medical team are particularly at risk of exposure to high viral load of coronavirus. They have also the best access to professional information regarding disease treatment and prophylaxis and disseminate such knowledge. The aim of the study was to assess the prevalence of use of T&CM for the prophylaxis of COVID 19 among the healthcare professionals and students in Jordan, along with the most common types and the factors associated with T&CM use. A cross-sectional study of T&CM use was conducted in Jordan using a snowball sampling method to distribute Google Forms and to enrol participants during coronavirus outbreak between June 10, 2021, and August 28, 2021. The study included healthcare professionals or students who consented to participate in the survey. The survey excluded those participants who had filled the questionnaire at least once or were pregnant/breast-feeding at the time of the study. The questionnaire consisted of 29 items, including screening, checkbox, dichotomous, matrix and open-ended questions. The response rate was 97.1%. Out of 560 study respondents, 359 (64.1%) reported using T&CM for COVID 19 prevention. Vitamins and nutrients were consumed by almost half (48.4%) of study participants, while nonpharmacological methods and herbal remedies were consumed by 35.2% and 25.2%, respectively. The most common source of information regarding T&CM use for COVID 19 prophylaxis included scientific publications (59.5%), followed by disease treatment guidelines (38.0%) and social media (32.3%). Adverse effects were reported by 8.5% and possible adverse effects were reported by another 8.5% of participants. The T&CM use was associated with working in contact with COVID 19 patients (OR: 1.625 (95% CI 1.047-2.523) (P = 0.03) and having a colleague as a source of information (OR: 1.720 (95% CI 1.026-2.883) (P = 0.04). The prevalence of T&CM use for COVID 19 prevention among healthcare professionals and students in Jordan is high, with a significant proportion of participants reporting adverse effects. There is an urgent need for further research toward efficacy and safety of T&CM in COVID 19 prophylaxis as well as development of appropriate public health policy on this issue specific to each country.
Identifiants
pubmed: 36264917
doi: 10.1371/journal.pone.0276015
pii: PONE-D-22-20162
pmc: PMC9584517
doi:
Substances chimiques
Vitamins
0
Minerals
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0276015Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Integr Med Res. 2022 Sep;11(3):100842
pubmed: 35308033
Am J Blood Res. 2020 Oct 15;10(5):266-282
pubmed: 33224571
Front Med (Lausanne). 2022 May 09;9:884573
pubmed: 35615091
Complement Ther Med. 2021 May;58:102682
pubmed: 33601014
Nat Rev Microbiol. 2022 May;20(5):270-284
pubmed: 35354968
J Ethnopharmacol. 2003 Dec;89(2-3):193-7
pubmed: 14611882
BMC Public Health. 2021 Jun 25;21(1):1226
pubmed: 34172042
Indian J Clin Biochem. 2021 Jan;36(1):108-111
pubmed: 33162692
Prev Med Rep. 2021 Dec;24:101633
pubmed: 34777985
J Integr Med. 2022 Jan;20(1):1-3
pubmed: 34896048
Evid Based Complement Alternat Med. 2022 Mar 16;2022:4559897
pubmed: 35310036
J Clin Exp Hepatol. 2021 Nov-Dec;11(6):732-738
pubmed: 34230786
Complement Ther Med. 2022 Mar;64:102792
pubmed: 34826590
Ann Ib Postgrad Med. 2021 Jun;19(Suppl 1):S22-S30
pubmed: 35095365
Holist Nurs Pract. 2022 Apr 05;:
pubmed: 35435866
Int J Clin Pract. 2021 Nov;75(11):e14860
pubmed: 34516713
Res Social Adm Pharm. 2022 Mar;18(3):2524-2528
pubmed: 33992585
Evid Based Complement Alternat Med. 2022 Feb 02;2022:9617429
pubmed: 35126606
PLoS One. 2020 Dec 11;15(12):e0243706
pubmed: 33306725
J Pharm Policy Pract. 2020 Jan 21;13:2
pubmed: 31988754
Value Health. 2005 Mar-Apr;8(2):94-104
pubmed: 15804318
Nutrients. 2020 Dec 27;13(1):
pubmed: 33375422
J Transl Med. 2020 Sep 15;18(1):353
pubmed: 32933536
Front Nutr. 2022 Mar 14;9:832321
pubmed: 35369061
JAMA Netw Open. 2021 Feb 1;4(2):e210369
pubmed: 33576820
Front Public Health. 2022 Feb 16;10:814669
pubmed: 35252093
J Med Internet Res. 2004 Sep 29;6(3):e34
pubmed: 15471760
ACS Infect Dis. 2022 Sep 9;8(9):1758-1814
pubmed: 35940589
BMC Public Health. 2021 Apr 8;21(1):684
pubmed: 33832446
Disaster Med Public Health Prep. 2020 Dec;14(6):782-788
pubmed: 32498749
BMJ Open. 2020 Oct 26;10(10):e040989
pubmed: 33109677
BMC Complement Med Ther. 2020 Nov 23;20(1):353
pubmed: 33225948
Orv Hetil. 2021 Oct 17;162(42):1678-1686
pubmed: 34656998
Rev Environ Health. 2021 Apr 12;36(3):443-450
pubmed: 33838089
BMC Public Health. 2021 Jan 6;21(1):58
pubmed: 33407321
JAMA Netw Open. 2021 Feb 1;4(2):e210431
pubmed: 33576814
Saudi Pharm J. 2022 Jun;30(6):856-862
pubmed: 35310539
Complement Ther Med. 2022 Aug;67:102824
pubmed: 35341943
J Ethnobiol Ethnomed. 2021 Apr 8;17(1):26
pubmed: 33832492
Holist Nurs Pract. 2021 Mar-Apr 01;35(2):98-107
pubmed: 33555723
Nutrition. 2021 May;85:111138
pubmed: 33578243
Public Health Nutr. 2021 Apr;24(5):861-869
pubmed: 33357253
BMC Complement Med Ther. 2022 Feb 15;22(1):43
pubmed: 35168630
Saudi Pharm J. 2020 Oct;28(10):1149-1154
pubmed: 32837218
Front Med (Lausanne). 2020 Dec 11;7:587749
pubmed: 33363186
J Integr Med. 2022 Jan;20(1):45-51
pubmed: 34840104